Showing results (71-80 of 111) with videos related to
Sort By:
Pageof 12
Clinical Drug Investigation|June 20, 2018
Correction to: Meta-analysis of Placebo Response in Randomized Clinical Trials of Antipsychotic Drugs Using PANSS Focusing on Different Approaches to the Handling of Missing DataAkiko Matsusaki, Masayuki Kaneko, Mamoru NarukawaClinical Drug Investigation|June 3, 2018
Meta-analysis of Placebo Response in Randomized Clinical Trials of Antipsychotic Drugs Using PANSS Focusing on Different Approaches to the Handling of Missing DataAkiko Matsusaki, Masayuki Kaneko, Mamoru NarukawaInternational Urology and Nephrology|April 14, 2018
Factors influencing efficacy endpoints in clinical trials for new oral medicinal treatments for overactive bladder: a systematic literature review and meta-analysisShingo Iino, Masayuki Kaneko, Mamoru NarukawaTherapeutic Innovation & Regulatory Science|February 3, 2020
Investigation of the Influencing Factors on the Incidence of Vertebral Fracture: A Meta-analysis Based on Placebo Data of Randomized Clinical TrialsTsuyoshi Kobayashi, Masayuki Kaneko, Mamoru NarukawaContemporary Clinical Trials Communications|November 29, 2021
Factors associated with successful phase III trials for solid tumors: A systematic reviewYasushi Otsuka, Masayuki Kaneko, Mamoru NarukawaTherapeutic Innovation & Regulatory Science|September 20, 2018
Factors Related to Regulatory Approval of Late-Stage Development Compounds: Analysis of Japanese Pharmaceutical Company Activities, 1995-2007Atsushi Tsukamoto, Masayuki Kaneko, Mamoru NarukawaBiological & Pharmaceutical Bulletin|January 13, 2025
Comparison of Oncology Drug Lag in Japan and South Korea Based on the Interval between the U.S. Approval and the Local ApprovalYoshifumi Tachibana, Jangsoo Yoon, Mamoru NarukawaPharmaceutical Medicine|January 23, 2021
Impact of Advantage in Tumor Response on the Correlation Between Progression-Free Survival and Overall Survival: Meta-Analysis of Clinical Trials in Patients with Advanced Non-Small Cell Lung CancerYosuke Yoshida, Masayuki Kaneko, Mamoru NarukawaPlos One|June 15, 2019
Lower-dose prescriptions in the post-marketing situation and the influencing factors thereonAkiko Ogata, Masayuki Kaneko, Mamoru NarukawaMenopause (New York, N.Y.)|January 27, 2022
Factors associated with high placebo response in clinical studies of hot flashes: a meta-analysisKentaro Miyazaki, Masayuki Kaneko, Mamoru NarukawaPageof 12